How many institutions held FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share in Q1 2023?

28 institutional investors reported FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share for Q1 2023. Use the holders table for investor-level position and value details.

Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX)

Q: What does CUSIP 34962G109 represent in this 13F holders report?

CUSIP 34962G109 is the security identifier for FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 34962G109

Q1 2023 13F Holders as of 31 Mar 2023

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 3,865,337
Total 13F value: $3,904,404
Share change: +62,355
Put/Call ratio: 0.53%
SEC-reported price per share: $1.01
Number of holders: 28
Value change: +$63,530
Number of buys: 8
Number of sells: 12
Shares outstanding: 20,563,488

Security key

34962G109

Report period

Q1 2023

Institutions

Top holders

FBRX full security history Ownership snapshot Full 13F holder table Forte Biosciences, Inc. SEC filings Forte Biosciences, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BML Capital Management, LLC

Disclosed value leader

BML Capital Management, LLC

Comparable rows

15/15

Latest evidence

31 Dec 2022

13F Lead comparable stake: 7.1% Showing 1-6 of 15 holder rows.

Quick read

BML Capital Management, LLC leads the comparable SEC ownership view at 7.1%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BML Capital Management, LLC's linked filing trail.

Comparable ownership Top 5

BML Capital Management, LLC 7.1%

VANGUARD GROUP INC 3.1%

Newtyn Management, LLC 2.7%

RENAISSANCE TECHNOLOGIES LLC 1.3%

BlackRock Finance, Inc. 1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BML Capital Management, LLC	13F Company 13F	7.1%	$1,461,364 1,461,364 shares	—	31 Dec 2022
VANGUARD GROUP INC	13F Company 13F	3.1%	$647,548 647,548 shares	—	31 Dec 2022
Newtyn Management, LLC	13F Company 13F	2.7%	$548,748 548,748 shares	—	31 Dec 2022
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	1.3%	$278,000 277,500 shares	—	31 Dec 2022
BlackRock Finance, Inc.	13F Company 13F	1%	$211,876 211,876 shares	—	31 Dec 2022
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	0.94%	$192,000 192,448 shares	—	31 Dec 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

3,865,337

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q1 2023 value	Value change	Value Chg %